Ross Finlay, a Co-founder and Director of the First Angel Network Association has been an angel investor since 2000. He has assisted many companies in raising private equity, is a Board Member of the National Angel Capital Organization (NACO), Director of the Angel Capital Association (ACA), and a Trustee of the Angel Resource Institute. Mr. Finlay is a recognized facilitator, senior business consulting professional and strategic change consultant who has an extensive background in public, private and not-for-profit sectors. He has implemented major business changes in a number of organizations and has experience in conducting organizational reviews in the public/private and the not-for-profit sectors. He has extensive business networks throughout Atlantic Canada. He has been Executive Director of a provincial professional association and President of a national consulting company working with scientific, engineering and technical areas. Since his move home to Nova Scotia, Ross has managed his own successful consulting practice. He returned to the corporate world for a time with PricewaterhouseCoopers LLP and SolutionInc Ltd. – a Halifax based software development company. In 2002 Ross was a recipient of the Queen Elizabeth II Jubilee Medal for outstanding community service through his efforts in numerous charities.
Brian E. Lowe
Brian E. Lowe is co-founder and director of the First Angel Network Association, Atlantic Canada’s largest association for private investors and is a shareholder and director of several operating companies throughout Atlantic Canada. As an accomplished entrepreneur and business leader with over 35 years experience, he has been involved in a number of start-up companies throughout his career. Mr. Lowe raised millions of dollars for these companies. He has been responsible for taking technologies to market internationally resulting in mergers and acquisitions. As a co-founder of Immunovaccine Technologies Inc., Mr. Lowe brought invaluable expertise having been responsible for the incorporation and raising the necessary start-up funding totalling $10 million. On October 5th, 2009, Immunovaccine Inc. (TSX-V: IMV) became a publicly traded company. Past experience includes serving as the President/CEO/Founder of three environmental companies based in Dartmouth, Nova Scotia. Mr. Lowe successfully negotiated the sale of these companies to Laidlaw Environmental Services Ltd. of South Carolina. He is the Chair of Bio Nova’s Board, Nova Scotia’s Industry Life Sciences Association, a past director of the National Angel Capital Association and the current Chair of Springboard Atlantic’s Board, a network with a mandate to support the commercialization of research throughout the 19 universities and colleges in Atlantic Canada. Mr. Lowe served the past seven years as Entrepreneur in Residence at the Norman Newman Centre for Entrepreneurship under the Faculty of Management at Dalhousie University.
Angela has been consulting with business owners for over 25 years. With a diverse industry background and experience in marketing, sales, human resources, production and finance, Angela is able to look at a company in a holistic way and see how all the individual parts come together to make a whole. With strengths in strategy development, team development, and negotiations, Angela works to find mutually beneficial solutions to intricate challenges. Angela is a former Board Member of the Institute of Professional Bookkeepers of Canada, as well as the Halifax Developmental Centre for Early Learning, and she currently sits on the Board of the Centennial Pool Association. In the role of Regional Chapter Director Angela will provide support to the Provincial Directors as well as the Members and Directors of FAN.